Join us on November 13th, 15:00 CET for a live session for life sciences commercial and marketing leaders.
Most CDMO and CRO marketing is still judged on leads. But a lead only records the moment a sponsor gets in touch.
A typical B2B purchase now involves 13 people inside the buyer’s organization and 9 outside it (Forrester, 2026). 94% of buying groups rank their shortlist before they contact a single supplier (6sense, 2025).
Most also research with AI models such as ChatGPT, Claude or Gemini (6sense, 2025). 84% of what those models cite is earned media, and just 0.3% is paid or advertorial (Muck Rack, 2026).
By the time a sponsor calls you, the shortlist is already written.
What this session covers
So what is advertising for, when it cannot buy you into the AI answer and leads arrive after the decision? Romano Heinz, Head of Strategy, Insights & Media at Sciential, makes the case for one goal: become the preferred partner before the RFP exists.
He shows how to build one account list with your commercial team, tracked for market signals and engagement. LinkedIn Ads and contextual programmatic then keep you in front of every buying group on it, week after week. Your experts’ LinkedIn content gives AI models something to cite.
It is strategic enough to change how you plan next year’s budget, and practical enough to start on Monday.
In 45 minutes, we will cover how to:
- Become the supplier sponsors rank first, before the RFP exists
- Earn a place in the AI answer when a sponsor asks which CDMO or CRO to call
- Build one account list with your commercial team, and let market signals tell you when to call
- Reach the whole buying group every week with ads they remember
- Decide whether ChatGPT Ads deserve budget now or a place on your watch list
- Prove progress without counting leads, and plan your first 90 days
Who should attend
- Marketing, commercial and business development leaders at CDMOs, CROs and other life sciences service providers
Save your seat👇
